reports
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
AMGN AMGEN INC.
MOD MODINE MANUFACTURING COMPANY
MKSI MKS INSTRUMENTS INC.
KHC KRAFT HEINZ COMPANY
IEP ICAHN ENTERPRISES L.P.
GIS GENERAL MILLS INC.
ENS ENERSYS
CL COLGATE-PALMOLIVE COMPANY
BWA BORGWARNER INC.
BLBD BLUE BIRD
BAX BAXTER INTERNATIONAL INC.
ATI ALLEGHENY TECHNOLOGIES INCORPORATED
AJRD AEROJET ROCKETDYNE HOLDINGS INC.
AEM. AGNICO EAGLE MINES LIMITED
NEM NEMETSCHEK SE
BRKS BROOKS AUTOMATION INC.
CMCO COLUMBUS MCKINNON CORPORATION
LMT LOCKHEED MARTIN CORPORATION
RDY DR. REDDY'S LABORATORIES LTD. ADS
CENTA CENTRAL GARDEN & PET CO A
VITL VITAL FARMS
UTZ UTZ BRANDS INC (A)
CAG ANGIANG PORT
IVI IVRNET INC.
SBTX SILVERBACK THERAPEUTICS
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Bulls Still In Driver's Seat, But For How Long? Continued encouraging COVID-19 news and accommodative moves by the Fed have allowed the bulls to remain in control while short-term support on the S&P 500 held near 2,450. While the bulls remain in control in the short-term, we continue to believe the broad equity market is not yet out of the woods and remains vulnerable -- particularly as Wall Street sentiment has flipped bullish. · Sector Relative Strength Rankings & Weighting Recommen...
1AMQ TEXTAINER GROUP HOLDINGS LIMITED
SWX SOUTHWEST GAS HOLDINGS INC.
QLYS QUALYS INC.
PLD PROLOGIS INC.
MSCI MSCI INC. CLASS A
MOH MOLINA HEALTHCARE INC.
MNOV MEDICINOVA
IMMU IMMUNOMEDICS INC.
HUM HUMANA INC.
EQT EQT CORPORATION
CYTK CYTOKINETICS INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
CNC CENTENE CORPORATION
CIEN CIENA CORPORATION
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CEMI CHEMBIO DIAGNOSTICS INC.
CDNS CADENCE DESIGN SYSTEMS INC.
CALA CALITHERA BIOSCIENCES INC.
BCOV BRIGHTCOVE
AMT AMERICAN TOWER CORPORATION
AMPH AMPHASTAR PHARMACEUTICALS INC
ABX. BARRICK GOLD CORPORATION
K. KINROSS GOLD CORPORATION
CHE CHEMED CORPORATION
CATS CATASYS INC.
STN. STANTEC INC
1059 METAIR INVESTMENTS LTD.
CCI CROWN CASTLE INTERNATIONAL CORP
RDY DR. REDDY'S LABORATORIES LTD. ADS
INSG INSEEGO CORP
SBAC SBA COMMUNICATIONS CORP. CLASS A
WPM WHEATON PRECIOUS METALS CORP
MRSN MERSANA THERAPEUTICS
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
KMDA KAMADA
BILI BILIBILI INC. SPONSORED ADR CLASS Z
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
DUBA DRDGOLD LTD. ADS
NBSE NEUBASE THERAPEUTICS
LVGO LIVONGO HEALTH
SQNS SEQUANS COMMUNICATIONS ADR
ZYXI ZYNEX
- Dave Nicoski
- Ross LaDuke
STZ CONSTELLATION BRANDS INC. CLASS A
NEM NEWMONT CORPORATION
TRNO TERRENO REALTY CORPORATION
QLYS QUALYS INC.
NTCT NETSCOUT SYSTEMS INC.
NDSN NORDSON CORPORATION
NDAQ NASDAQ INC.
MSCI MSCI INC. CLASS A
MOH MOLINA HEALTHCARE INC.
MNOV MEDICINOVA
FFIV F5 NETWORKS INC.
FE FIRSTENERGY CORP.
CTMX CYTOMX THERAPEUTICS INC.
CNC CENTENE CORPORATION
CIEN CIENA CORPORATION
AMT AMERICAN TOWER CORPORATION
ABX. BARRICK GOLD CORPORATION
CHE CHEMED CORPORATION
CCI CROWN CASTLE INTERNATIONAL CORP
CMG CHIPOTLE MEXICAN GRILL INC.
ENTG ENTEGRIS INC.
HTLD HEARTLAND EXPRESS INC.
MRTN MARTEN TRANSPORT LTD.
WLTW WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY
RDY DR. REDDY'S LABORATORIES LTD. ADS
FIZZ NATIONAL BEVERAGE CORP.
INSG INSEEGO CORP
SBAC SBA COMMUNICATIONS CORP. CLASS A
SPGI S&P GLOBAL INC.
MRSN MERSANA THERAPEUTICS
BAND BANDWIDTH CLASS A
PDD PINDUODUO INC. SPONSORED ADR CLASS A
A2DSYC LINDE PLC
AMCR AMCOR PLC
NBSE NEUBASE THERAPEUTICS
GNMSY GENMAB A/S
NVAX NOVAVAX INC.
LVGO LIVONGO HEALTH
ARES ARES MANAGEMENT CORPORATION
SQNS SEQUANS COMMUNICATIONS ADR
ZYXI ZYNEX
MTA HA TINH MINERALS & TRADING CORP.
- Dave Nicoski
- Ross LaDuke
INCY INCYTE CORP
VMW VMWARE INC. CLASS A
WING WINGSTOP INC.
USNA USANA HEALTH SCIENCES INC.
TER TERADYNE INC.
SLGN SILGAN HOLDINGS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
QLYS QUALYS INC.
NTGR NETGEAR INC.
NTCT NETSCOUT SYSTEMS INC.
NG. NOVAGOLD RESOURCES INC.
MOH MOLINA HEALTHCARE INC.
IPHI INPHI CORPORATION
HUM HUMANA INC.
FFIV F5 NETWORKS INC.
EQT EQT CORPORATION
DIOD DIODES INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
CTLT CATALENT INC
CNC CENTENE CORPORATION
CHTR CHARTER COMMUNICATIONS INC. CLASS A
BMY BRISTOL-MYERS SQUIBB COMPANY
BCOV BRIGHTCOVE
ALXN ALEXION PHARMACEUTICALS INC.
MRVL MARVELL TECHNOLOGY GROUP LTD.
CAT CATERPILLAR INC.
FIVN FIVE9 INC.
CATS CATASYS INC.
STN. STANTEC INC
CMG IEX GROUP
HRC CHIPOTLE MEXICAN GRILL INC.
HTLD HILL-ROM HOLDINGS INC.
ODFL HEARTLAND EXPRESS INC.
TDC OLD DOMINION FREIGHT LINE INC.
WERN TERADATA CORPORATION
WLTW WERNER ENTERPRISES INC.
RDY WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY
FIZZ DR. REDDY'S LABORATORIES LTD. ADS
SBAC NATIONAL BEVERAGE CORP.
ASML DIOD
MRSN SBA COMMUNICATIONS CORP. CLASS A
JNPR ASML HOLDING N.V.
INVA MERSANA THERAPEUTICS
A2DSYC JUNIPER NETWORKS INC.
LVGO INNOVIVA INC.
LINDE PLC
LIVONGO HEALTH
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Encouraging Signs, But Not Out Of The Woods Positive news flow surrounding COVID-19 is encouraging on many fronts, and we welcome headlines such as peaking infections/deaths in Italy & Spain, certain European governments making plans to ease lockdowns, and that US death projections were likely overestimated. Despite encouraging news and the S&P 500 (SPX) hitting multi-week highs, market signals continue to suggest that this is a fairly standard bear market rally, making us believe the broad equ...
INCY INCYTE CORP
XLNX XILINX INC.
WST WEST PHARMACEUTICAL SERVICES INC.
VRTX VERTEX PHARMACEUTICALS INCORPORATED
SNYN SANOFI S.A. ADS
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
POST POST HOLDINGS INC.
NVDA NVIDIA CORPORATION
NTCT NETSCOUT SYSTEMS INC.
MKTX MARKETAXESS HOLDINGS INC.
MCO MOODY'S CORPORATION
JNJ JOHNSON & JOHNSON
IPHI INPHI CORPORATION
INTC INTEL CORPORATION
HRL HORMEL FOODS CORPORATION
DG DOLLAR GENERAL CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
CTLT CATALENT INC
CHTR CHARTER COMMUNICATIONS INC. CLASS A
BPMC BLUEPRINT MEDICINES CORP.
ASTE ASTEC INDUSTRIES INC.
ALXN ALEXION PHARMACEUTICALS INC.
UNP UNION PACIFIC CORPORATION
VIRT VIRTU FINANCIAL INC. CLASS A
K. KINROSS GOLD CORPORATION
CATS CATASYS INC.
CCO. CAMECO CORPORATION
STN. STANTEC INC
CAH CARDINAL HEALTH INC.
PETS PETMED EXPRESS INC.
RDY DR. REDDY'S LABORATORIES LTD. ADS
WMK WEIS MARKETS INC.
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
WPM WHEATON PRECIOUS METALS CORP
ARNA ARENA PHARMACEUTICALS INC.
JNPR JUNIPER NETWORKS INC.
CTXS CITRIX SYSTEMS INC.
BAND BANDWIDTH CLASS A
MRNA MODERNA INC.
TW TRADEWEB MARKETS INC. CLASS A
NBSE NEUBASE THERAPEUTICS
GO GROCERY OUTLET HOLDING
LVGO LIVONGO HEALTH
YY JOYY
INC.
- Dave Nicoski
- Ross LaDuke
INCY INCYTE CORP
PEP PEPSICO INC.
VRTX VERTEX PHARMACEUTICALS INCORPORATED
SNYN SANOFI S.A. ADS
SLGN SILGAN HOLDINGS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SFM SPROUTS FARMERS MARKETS INC.
RNG RINGCENTRAL INC. CLASS A
RMD RESMED INC.
QLYS QUALYS INC.
POST POST HOLDINGS INC.
PBH PRESTIGE CONSUMER HEALTHCARE INC
NG. NOVAGOLD RESOURCES INC.
MKTX MARKETAXESS HOLDINGS INC.
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
MC MOELIS & CO. CLASS A
LLNW LIMELIGHT NETWORKS
IPHI INPHI CORPORATION
INTC INTEL CORPORATION
ICE INTERCONTINENTAL EXCHANGE INC.
HLI HOULIHAN LOKEY INC. CLASS A
HAIN HAIN CELESTIAL GROUP INC.
FFIV F5 NETWORKS INC.
EXPO EXPONENT INC.
EXPD EXPEDITORS INTERNATIONAL OF WASHINGTON INC.
EQIX EQUINIX INC.
DG DOLLAR GENERAL CORPORATION
CIEN CIENA CORPORATION
CAG CONAGRA BRANDS INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
AUDC AUDIOCODES LTD.
ATVI ACTIVISION BLIZZARD INC.
ASTE ASTEC INDUSTRIES INC.
AMT AMERICAN TOWER CORPORATION
ALXN ALEXION PHARMACEUTICALS INC.
ABX. BARRICK GOLD CORPORATION
CNR. CANADIAN NATIONAL RAILWAY COMPANY
VIRT VIRTU FINANCIAL INC. CLASS A
CP. CANADIAN PACIFIC RAILWAY LIMITED
FF FUTUREFUEL CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
CHE CHEMED CORPORATION
FIVN FIVE9 INC.
CCO. CAMECO CORPORATION
RBA RITCHIE BROS. AUCTIONEERS INCORPORATED
PIT PITTLER MASCHINENFABRIK AG
CAH CARDINAL HEALTH INC.
CCI CROWN CASTLE INTERNATIONAL CORP
EA ELECTRONIC ARTS INC.
HRC HILL-ROM HOLDINGS INC.
HRI HERC HOLDINGS INC.
LMT LOCKHEED MARTIN CORPORATION
NVS.. NOVARTIS AG ADS
RDY DR. REDDY'S LABORATORIES LTD. ADS
WMK WEIS MARKETS INC.
BMTA BRITISH AMERICAN TOBACCO PLC ADS
PHI PHILIPPINE LONG DISTANCE TELEPHONE COMPANY ADS
NMI. KIRKLAND LAKE GOLD LTD.
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
PFE PFIZER INC.
NOMDN NOMAD FOODS LTD.
ARNA ARENA PHARMACEUTICALS INC.
KALA KALA PHARMACEUTICALS INC.
RTP.. RIO TINTO PLC ADS (MEXICO)
JNPR JUNIPER NETWORKS INC.
CTXS CITRIX SYSTEMS INC.
ZS ZSCALER INC.
AZN ASTRAZENECA PLC ADS
KNSA KINIKSA PHARMACEUTICALS
TRI THOMSON REUTERS CORPORATION
MRNA MODERNA INC.
VAPO VAPOTHERM
NVAX NOVAVAX INC.
XAIR BEYOND AIR
NET CLOUDFLARE INC CLASS A
YY JOYY
INC.
- Dave Nicoski
- Ross LaDuke
VEEV VEEVA SYSTEMS INC CLASS A
PGR PROGRESSIVE CORPORATION
WABC WESTAMERICA BANCORPORATION
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SPSC SPS COMMERCE INC.
SNYN SANOFI S.A. ADS
SNP CHINA PETROLEUM & CHEMICAL CORP. ADS
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFM SPROUTS FARMERS MARKETS INC.
RGR STURM RUGER & COMPANY INC.
REGN REGENERON PHARMACEUTICALS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NEH NETEASE INC. SPONSORED ADR
NTCT NETSCOUT SYSTEMS INC.
MSCI MSCI INC. CLASS A
LMNX LUMINEX CORP
LAKE LAKELAND INDUSTRIES INC.
INDB INDEPENDENT BANK CORP.
IBKR INTERACTIVE BROKERS GROUP INC. CLASS A
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
HLI HOULIHAN LOKEY INC. CLASS A
GGG GRACO INC.
FFIV F5 NETWORKS INC.
EXPD EXPEDITORS INTERNATIONAL OF WASHINGTON INC.
DG DOLLAR GENERAL CORPORATION
CEMI CHEMBIO DIAGNOSTICS INC.
ASTE ASTEC INDUSTRIES INC.
ALXN ALEXION PHARMACEUTICALS INC.
ABX. BARRICK GOLD CORPORATION
UNP UNION PACIFIC CORPORATION
46H HOLLYSYS AUTOMATION TECHNOLOGIES LTD.
FF FUTUREFUEL CORP.
CHE CHEMED CORPORATION
PJT PJT PARTNERS INC. CLASS A
CAT CATERPILLAR INC.
G ASSICURAZIONI GENERALI S.P.A.
CATS CATASYS INC.
BRK.B BERKSHIRE HATHAWAY INC. CLASS B
DSPG DSP GROUP INC.
HRC
LMT HILL-ROM HOLDINGS INC.
PETS LOCKHEED MARTIN CORPORATION
RDY PETMED EXPRESS INC.
WMK DR. REDDY'S LABORATORIES LTD. ADS
PFE WEIS MARKETS INC.
RTP.. PFIZER INC.
JNPR RIO TINTO PLC ADS (MEXICO)
BILI JUNIPER NETWORKS INC.
TW BILIBILI INC. SPONSORED ADR CLASS Z
XAIR TRADEWEB MARKETS INC. CLASS A
LHX BEYOND AIR
BLU L3HARRIS TECHNOLOGIES INC
BLUE ENERGY
- Dave Nicoski
- Ross LaDuke
XLRN ACCELERON PHARMA INC
TECH BIO-TECHNE CORPORATION
STX SEAGATE TECHNOLOGY PLC
SNP CHINA PETROLEUM & CHEMICAL CORP. ADS
SLGN SILGAN HOLDINGS INC.
SGEN SEAGEN INC.
RTRX TRAVERE THERAPEUTICS INC.
PBH PRESTIGE CONSUMER HEALTHCARE INC
PAHC PHIBRO ANIMAL HEALTH CORPORATION CLASS A
IPHI INPHI CORPORATION
INGR INGREDION INCORPORATED
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
FTNT FORTINET INC.
ERICn TELEFONAKTIEBOLAGET LM ERICSSON
CTSO CYTOSORBENTS
CTMX CYTOMX THERAPEUTICS INC.
CIEN CIENA CORPORATION
BMY BRISTOL-MYERS SQUIBB COMPANY
BMRN BIOMARIN PHARMACEUTICAL INC.
AUDC AUDIOCODES LTD.
ASTE ASTEC INDUSTRIES INC.
ALXN ALEXION PHARMACEUTICALS INC.
A AGILENT TECHNOLOGIES INC.
CAT CATERPILLAR INC.
GLD SPDR GOLD TRUST
NVA NUVISTA ENERGY LTD.
HRC HILL-ROM HOLDINGS INC.
RDY DR. REDDY'S LABORATORIES LTD. ADS
VSTO VISTA OUTDOOR INC
UTHR UNITED THERAPEUTICS CORPORATION
KALA KALA PHARMACEUTICALS INC.
RTP.. RIO TINTO PLC ADS (MEXICO)
INVA INNOVIVA INC.
AZN ASTRAZENECA PLC ADS
GNMSY GENMAB A/S
VCR VANGUARD CONSUMER DISCRETIONAR
- Dave Nicoski
- Ross LaDuke
SHOP SHOPIFY INC.
TSFA TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD. SPONSORED ADR
NEM NEWMONT CORPORATION
DPZ DOMINO'S PIZZA INC.
LITE LUMENTUM HOLDINGS INC.
BLUE BLUEBIRD BIO INC.
IZZ TAL EDUCATION GROUP SPONSORED ADR CLASS A
XLRN ACCELERON PHARMA INC
WING WINGSTOP INC.
V VISA INC. CLASS A
SNE. SONY CORP. (ADS)
SINA SINA CORP.
RNG RINGCENTRAL INC. CLASS A
RLI RLI CORP.
NVMI NOVA MEASURING INSTRUMENTS LTD
NVDA NVIDIA CORPORATION
NEH NETEASE INC. SPONSORED ADR
NG. NOVAGOLD RESOURCES INC.
NEO NEOGENOMICS INC.
MSCI MSCI INC. CLASS A
MPWR MONOLITHIC POWER SYSTEMS INC.
MELLANOX TECHNOLOGIES LTD.
JD JD.COM INC. SPONSORED ADR CLASS A
IPHI INPHI CORPORATION
INTC INTEL CORPORATION
FTNT FORTINET INC.
FOLD AMICUS THERAPEUTICS INC.
FNV. FRANCO-NEVADA CORPORATION
FAN FABRINET
FDX FEDEX CORPORATION
EXPD EXPEDITORS INTERNATIONAL OF WASHINGTON INC.
ESE ESCO TECHNOLOGIES INC.
EHTH EHEALTH INC.
N1U NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. SPONSORED ADR
ECHO ECHO GLOBAL LOGISTICS INC
DQ DAQO NEW ENERGY CORP SPONSORED ADR
CTLT CATALENT INC
CDNS CADENCE DESIGN SYSTEMS INC.
A117ME ALIBABA GROUP HOLDING LTD. SPONSORED ADR
AU ANGLOGOLD ASHANTI LTD. ADS
ASTE ASTEC INDUSTRIES INC.
ALXN ALEXION PHARMACEUTICALS INC.
CNR. CANADIAN NATIONAL RAILWAY COMPANY
BRK.B BERKSHIRE HATHAWAY INC. CLASS B
HMCn WORKPOINT ENTERTAINMENT PCL
MRTN HONDA MOTOR ADS
NVS.. MARTEN TRANSPORT LTD.
ODFL NOVARTIS AG ADS
WERN OLD DOMINION FREIGHT LINE INC.
WUBA WERNER ENTERPRISES INC.
RDY 58.COM INC. SPONSORED ADR CLASS A
CIA DR. REDDY'S LABORATORIES LTD. ADS
JBHT CITIZENS INC. CL A
EVBG J.B. HUNT TRANSPORT SERVICES INC.
UTHR EVERBRIDGE INC.
YUMC UNITED THERAPEUTICS CORPORATION
ABX.. YUM CHINA HOLDINGS INC.
AXON BARRICK GOLD CORP.
ASML AXON ENTERPRISE INC
WPM ASML HOLDING N.V.
FANH WHEATON PRECIOUS METALS CORP
SE FANHUA ADS (N SHARES)
JNPR SEA ADS
AMD JUNIPER NETWORKS INC.
HMI ADVANCED MICRO DEVICES INC.
ZS HUAMI ADS (N SHARES)
SWCH ZSCALER INC.
AVLR SWITCH
JWA AVALARA INC
PLMR JWA SA
WORK PALOMAR HOLDINGS
ARCT SLACK TECHNOLOGIES INC. CLASS A
YY ARCTURUS THERAPEUTICS HOLDINGS INC
JOYY
INC.
- Damien Conover
Morningstar | Dr. Reddy's Fiscal Fourth-Quarter Results Broadly Met Ou...
Dr. Reddy's fiscal fourth-quarter results mostly tracked our expectations. While the company's North American generics top line continued to improve, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue performance was healthy across regions during the quarter. The segment's overall revenue grew by roughly 9%, with robust strength across the board. Dr. Reddy's generic drug revenue saw roughly 27% growth...
- Damien Conover
Morningstar | Dr. Reddy's Fiscal Fourth-Quarter Results Broadly Met Ou...
Dr. Reddy's fiscal fourth-quarter results mostly tracked our expectations. While the company's North American generics top line continued to improve, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue performance was healthy across regions during the quarter. The segment's overall revenue grew by roughly 9%, with robust strength across the board. Dr. Reddy's generic drug revenue saw roughly 27% growth...
- Damien Conover
Morningstar | RDY Updated Forecasts and Estimates from 05 Jul 2019
Dr. Reddy's fiscal fourth-quarter results mostly tracked our expectations. While the company's North American generics top line continued to improve, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue performance was healthy across regions during the quarter. The segment's overall revenue grew by roughly 9%, with robust strength across the board. Dr. Reddy's generic drug revenue saw roughly 27% growth...
- Damien Conover
Morningstar | Dr. Reddy's Fiscal Fourth-Quarter Results Broadly Met Ou...
Dr. Reddy's fiscal fourth-quarter results mostly tracked our expectations. While the company's North American generics top line continued to improve, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue performance was healthy across regions during the quarter. The segment's overall revenue grew by roughly 9%, with robust strength across the board. Dr. Reddy's generic drug revenue saw roughly 27% growth...
- Damien Conover
Dr. Reddy's Fiscal Fourth-Quarter Results Broadly Met Our Expectations
Dr. Reddy's fiscal fourth-quarter results mostly tracked our expectations. While the company's North American generics top line continued to improve, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue performance was healthy across regions during the quarter. The segment's overall revenue grew by roughly 9%, with robust strength across the board. Dr. Reddy's generic drug revenue saw roughly 27% growth ...
- Damien Conover
Morningstar | Dr. Reddy’s Is Well-Positioned for Growth, but We Cont...
Dr. Reddy's ongoing penetration of the U.S. generics market and and emerging-market exposure add up to attractive growth prospects. The company has an established brand in many emerging markets where rising disposable income, a fragmented customer base, and lower generic drug utilization rates offer attractive growth opportunities. Since many global drug markets lack a consolidated and efficient drug distribution infrastructure, generic drug manufacturers generally sell most of their product--fr...
- Damien Conover
Dr. Reddy’s Is Well-Positioned for Growth, but We Continue to View t...
Dr. Reddy's fiscal third-quarter results largely tracked our expectations. While the company's North American generics revenue is showing early signs of stabilization, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue was mixed across regions during the quarter. The segment's overall revenue grew by roughly 4% thanks to emerging-market performance, and we think brand recognition of Dr. Reddy's in eme...
- Michael Waterhouse
Morningstar | Dr. Reddy's Fiscal 3Q Results Track Expectations; U.S. P...
Dr. Reddy's fiscal third-quarter results largely tracked our expectations. While the company's North American generics revenue is showing early signs of stabilization, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue was mixed across regions during the quarter. The segment's overall revenue grew by roughly 4% thanks to emerging-market performance, and we think brand recognition of Dr. Reddy's in eme...
- Michael Waterhouse
Dr. Reddy's Fiscal 3Q Results Track Expectations; U.S. Price Erosion P...
Dr. Reddy's fiscal third-quarter results largely tracked our expectations. While the company's North American generics revenue is showing early signs of stabilization, we don't anticipate any major changes to our fair value estimate, and we are reiterating our no-moat rating. The company's global generic revenue was mixed across regions during the quarter. The segment's overall revenue grew by roughly 4% thanks to emerging-market performance, and we think brand recognition of Dr. Reddy's in eme...
- Michael Waterhouse
Dr. Reddy's Low Cost Operations and Emerging Market Brand Recognition ...
Dr. Reddy's fiscal second-quarter results provided no major surprises to us. We don't anticipate making major changes to our fair value estimate, and we’re also reiterating our no-moat rating. The company's global generic revenue was mixed across regions during the quarter. The segment's overall revenue grew by roughly 7% thanks to emerging-market performance, and we think Dr. Reddy's relative brand recognition in emerging markets will continue to bode well for its performance. The company exp...
- Michael Waterhouse
Morningstar | Dr. Reddy's Fiscal 2Q Performance Provides No Major Surp...
Dr. Reddy's fiscal second-quarter results provided no major surprises to us. We don't anticipate making major changes to our fair value estimate, and we’re also reiterating our no-moat rating. The company's global generic revenue was mixed across regions during the quarter. The segment's overall revenue grew by roughly 7% thanks to emerging-market performance, and we think Dr. Reddy's relative brand recognition in emerging markets will continue to bode well for its performance. The company ex...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.